01 2AVELUMAB
02 2CETRORELIX ACETATE
03 2CHORIOGONADOTROPIN ALFA
04 1CLADRIBINE
05 1CLOMIPHENE CITRATE
06 12FOLLITROPIN ALFA/BETA
07 2INTERFERON BETA-1A
08 23LEVOTHYROXINE SODIUM
09 2MENOTROPINS (FSH;LH)
10 7METFORMIN HYDROCHLORIDE
11 4MITOXANTRONE HYDROCHLORIDE
12 3SERMORELIN ACETATE
13 9SOMATROPIN
14 4SOMATROPIN RECOMBINANT
15 1TEPOTINIB HYDROCHLORIDE
16 4UROFOLLITROPIN
01 1INJECTABLE; INJECTION
02 22INJECTABLE;INJECTION
03 2INJECTABLE;INTRAMUSCULAR
04 1INJECTABLE;INTRAVENOUS
05 16INJECTABLE;SUBCUTANEOUS
06 2POWDER;SUBCUTANEOUS
07 2SYRINGE
08 2TABLET, EXTENDED RELEASE;ORAL
09 31TABLET;ORAL
01 10.025MG
02 10.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
03 10.05MG
04 10.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
05 10.075MG
06 10.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
07 10.088MG
08 10.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
09 10.112MG
10 10.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
11 10.125MG
12 10.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
13 10.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
14 10.15MG
15 10.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
16 10.175MG
17 10.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
18 10.1MG
19 10.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
20 10.25MG/VIAL
21 10.2MG
22 10.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
23 20.3MG
24 11,050 IU/VIAL
25 110MG
26 1150 IU/0.25ML
27 2150 IU/AMP
28 1150 IU/AMP;150 IU/AMP
29 2150 IU/VIAL
30 11GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
31 220MG/ML
32 122UG/0.5ML
33 1300 IU/0.5ML
34 237.5 IU/VIAL
35 144UG/0.5ML
36 1450 IU/0.75ML
37 1450 IU/VIAL
38 34MG/VIAL
39 2500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
40 150MG
41 35MG/VIAL
42 1625MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
43 16MG/0.5ML (6MG/0.5ML)
44 36MG/VIAL
45 275 IU/AMP
46 175 IU/AMP;75 IU/AMP
47 275 IU/VIAL
48 2750MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
49 38.8MG/VIAL
50 1850MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
51 1900 IU/1.5ML
52 1EQ 0.05MG BASE/AMP **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
53 1EQ 0.25MG /0.5ML
54 1EQ 0.25MG BASE/VIAL
55 1EQ 0.5MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
56 1EQ 1MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
57 1EQ 20MG BASE/10ML (EQ 2MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
58 1EQ 225MG BASE
59 1EQ 25MG BASE/12.5ML (EQ 2MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
60 1EQ 2MG BASE/ML
61 1EQ 30MG BASE/15ML (EQ 2MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
62 1EQ 3MG BASE/VIAL
01 27DISCN
02 14RX
03 38Blank
RLD :
TE Code :
Dosage Form : INJECTABLE; INJECTION
Proprietary Name : BAVENCIO
Dosage Strength : 20MG/ML
Approval Date :
Application Number : 761049
RX/OTC/DISCN :
RLD :
TE Code :
RLD :
TE Code :
Dosage Form : INJECTABLE; INTRAVENOUS
Proprietary Name : BAVENCIO
Dosage Strength : 20MG/ML
Approval Date :
Application Number : 761078
RX/OTC/DISCN :
RLD :
TE Code :
RLD : Yes
TE Code : AP
Dosage Form : POWDER; SUBCUTANEOUS
Proprietary Name : CETROTIDE
Dosage Strength : EQ 0.25MG BASE/VIAL
Approval Date : 2000-08-11
Application Number : 21197
RX/OTC/DISCN : RX
RLD : Yes
TE Code : AP
RLD : Yes
TE Code :
Dosage Form : POWDER; SUBCUTANEOUS
Proprietary Name : CETROTIDE
Dosage Strength : EQ 3MG BASE/VIAL
Approval Date : 2000-08-11
Application Number : 21197
RX/OTC/DISCN : DISCN
RLD : Yes
TE Code :
RLD :
TE Code :
Dosage Form : INJECTABLE; INJECTION
Proprietary Name : OVIDREL
Dosage Strength : 0.25MG/VIAL
Approval Date :
Application Number : 21149
RX/OTC/DISCN :
RLD :
TE Code :
RLD :
TE Code :
Dosage Form : INJECTABLE; SUBCUTANEOUS
Proprietary Name : OVIDREL
Dosage Strength : EQ 0.25MG /0.5ML
Approval Date :
Application Number : 21149
RX/OTC/DISCN :
RLD :
TE Code :
RLD : Yes
TE Code :
Dosage Form : TABLET; ORAL
Proprietary Name : MAVENCLAD
Dosage Strength : 10MG
Approval Date : 2019-03-29
Application Number : 22561
RX/OTC/DISCN : RX
RLD : Yes
TE Code :
RLD : No
TE Code :
Dosage Form : TABLET; ORAL
Proprietary Name : SEROPHENE
Dosage Strength : 50MG
Approval Date : 1982-03-22
Application Number : 18361
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD :
TE Code :
Dosage Form : INJECTABLE; SUBCUTANEOUS
Proprietary Name : GONAL-F
Dosage Strength : 37.5 IU/VIAL
Approval Date :
Application Number : 21765
RX/OTC/DISCN :
RLD :
TE Code :
RLD :
TE Code :
Dosage Form : INJECTABLE; SUBCUTANEOUS
Proprietary Name : GONAL-F RFF
Dosage Strength : 75 IU/VIAL
Approval Date :
Application Number : 21765
RX/OTC/DISCN :
RLD :
TE Code :
Merck Group is a supplier offers 27 products (APIs, Excipients or Intermediates).
Find a price of Bisoprolol Fumarate bulk with DMF, CEP offered by Merck Group
Find a price of Boric Acid bulk with DMF, CEP offered by Merck Group
Find a price of Calcium Chloride bulk with DMF, CEP offered by Merck Group
Find a price of Magnesium Chloride bulk with DMF, CEP offered by Merck Group
Find a price of Meglumine bulk with DMF, CEP offered by Merck Group
Find a price of Potassium Iodide bulk with DMF, CEP offered by Merck Group
Find a price of Potassium Phosphate bulk with DMF, CEP offered by Merck Group
Find a price of Praziquantel bulk with DMF, CEP offered by Merck Group
Find a price of Sodium Acetate Trihydrate bulk with DMF, CEP offered by Merck Group
Find a price of Urea API bulk with DMF, CEP offered by Merck Group
Find a price of Safinamide Methanesulfonate bulk with JDMF offered by Merck Group
Find a price of Sodium Fluoride bulk with CEP offered by Merck Group
Find a price of Trisodium Citrate Dihydrate bulk with DMF offered by Merck Group
Find a price of Zinc Dichloride bulk with CEP offered by Merck Group
Find a price of BENZONASE SAFETY PLUS bulk with DMF offered by Merck Group
Find a price of Medium / medium additive · X011Sb Cell Culture Medium bulk with JDMF offered by Merck Group
Find a price of Medium / Medium Additives FX-208 Cell Culture Medium bulk with JDMF offered by Merck Group
Find a price of Medium / Medium Additives MX-209 Cell Culture Medium bulk with JDMF offered by Merck Group
Find a price of Ascorbic Acid bulk offered by Merck Group
Find a price of Calcium Carbonate bulk offered by Merck Group
Find a price of Cilengitide bulk offered by Merck Group
Find a price of Mannitol API bulk offered by Merck Group
Find a price of Pentetic Acid bulk offered by Merck Group
Find a price of Recombinant Human Growth Hormone bulk offered by Merck Group
Find a price of Sodium Acetate bulk offered by Merck Group
Find a price of Vilazodone Hydrochloride bulk offered by Merck Group
Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN ALCALA, SPAIN. bulk offered by Merck Group
